Serina Therapeutics Inc [AMEX: SER] gained 3.70% or 0.19 points to close at $5.32 with a heavy trading volume of 164299 shares.
It opened the trading session at $5.19, the shares rose to $5.4444 and dropped to $5.02, the range by which the price of stock traded the whole day. The daily chart for SER points out that the company has recorded 12.24% gains over the past six months.
If we look at the average trading volume of 114.08K shares, SER reached to a volume of 164299 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Serina Therapeutics Inc [SER]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SER shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SER stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Serina Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 14, 2025.
Trading performance analysis for SER stock
Serina Therapeutics Inc [SER] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.84. With this latest performance, SER shares dropped by -3.97% in over the last four-week period, additionally plugging by 12.24% over the last 6 months – not to mention a rise of 6.19% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SER stock in for the last two-week period is set at 48.71, with the RSI for the last a single of trading hit 0.61, and the three-weeks RSI is set at 0.52 for Serina Therapeutics Inc [SER]. The present Moving Average for the last 50 days of trading for this stock 5.51, while it was recorded at 5.31 for the last single week of trading, and 5.25 for the last 200 days.
Serina Therapeutics Inc [SER]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Serina Therapeutics Inc [SER] shares currently have an operating margin of -11951.59% and a Gross Margin at -36.51%. Serina Therapeutics Inc’s Net Margin is presently recorded at -4983.33%.
Serina Therapeutics Inc (SER) Capital Structure & Debt Analysis
Serina Therapeutics Inc (SER) Efficiency & Liquidity Metrics
Based on Serina Therapeutics Inc’s (SER) latest financial statements, the Debt-to-Equity Ratio is 0.20%, indicating its reliance on debt financing relative to shareholder equity.
Serina Therapeutics Inc (SER) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Serina Therapeutics Inc. (SER) effectively leverages its workforce, generating an average of -$483076.92 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.24% and a Quick Ratio of 2.24%, indicating strong ability to cover short-term liabilities.
Serina Therapeutics Inc [SER]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Serina Therapeutics Inc posted -0.66/share EPS, while the average EPS was predicted by analysts to be reported at -0.43/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.24. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SER.
An analysis of Institutional ownership at Serina Therapeutics Inc [SER]
There are presently around $4.03%, or 10.63%% of SER stock, in the hands of institutional investors. The top three institutional holders of SER stocks are: BROADWOOD CAPITAL INC with ownership of 85219.0 shares, which is approximately 1.0009%. WAVERLY ADVISORS, LLC, holding 23485.0 shares of the stock with an approximate value of $$0.22 million in SER stocks shares; and WAVERLY ADVISORS, LLC, currently with $$0.22 million in SER stock with ownership which is approximately 0.2672%.
